CryoXtract Gets Financial Support for Automated Frozen Sample Aliquotter

CryoXtract has received huge financial aid towards the commercialization of its Automated Frozen Sample Aliquotter. The automated aliquotter is useful in applications such as biobanking, molecular medicine and biomarker discovery, where the sample is not required to go through repeated freeze-thaw cycles.

This robotic solution would enable extraction of frozen aliquots from frozen serum or plasma samples without the need for physical contact. Allied Minds stated that the funds would be first used to launch the automated aliquotter.

This technology was conceived through the joint effort of Dale Larson from the Harvard Medical School and Northeastern University. This method of extraction is hands-free and does not require the sample to be thawed for extraction, thereby, the integrity and standard of the sample is not altered. The robotic probe extracts the frozen sample and deposits it on to separate cryotubes that transport the sample for further analyses. The extracted sample remains frozen throughout the process and remnants of the sample in the cryotube can be returned to the storage in its original form. Experiments with the automated aliquotter proved its ability to extract multiple samples from one single cryotube containing frozen human plasma. Chris Silva, CEO of Allied Minds, revealed his plans of introducing the Automated Aliquotter in the market next year.